WHO selects Taiwan's Medigen COVID-19 vaccine for international trial

A COVID-19 vaccine developed by Taiwan's Medigen Vaccine Biologics Corp. has been chosen to take part in an international clinical trial platform co-launched by the World Health Organization (WHO), according to a statement released by the organization Tuesday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)